title: Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
abstract: Chemotherapy induced peripheral neuropathy [CIPN] is a common significant and debilitating side effect resulting from the administration of neurotoxic chemotherapeutic agents. These pharmaco-chemotherapeutics can include taxanes, vinca alkaloids and others. Moderate to severe CIPN significantly decreases the quality of life and physical abilities of cancer patients and current pharmacotherapy for CIPN e.g. Amifostine and antidepressants have had limited efficacy and may themselves induce adverse side effects. To determine the potential use of nutraceuticals i.e. vitamin E, acetyl-L-carnitine, glutamine, glutathione, vitamin B6, omega-3 fatty acids, magnesium, calcium, alpha lipoic acid and n-acetyl cysteine as adjuvants in cancer treatments a systematic literature review was conducted. Revised clinical studies comprised of randomized clinical trials that investigated the anti-CIPN effect of nutraceuticals as the adjuvant intervention in patients administered chemotherapy. Twenty-four studies were assessed on methodological quality and limitations identified. Studies were mixed in their recommendations for nutraceuticals. Currently no agent has shown solid beneficial evidence to be recommended for the treatment or prophylaxis of CIPN. The standard of care for CIPN includes dose reduction and/or discontinuation of chemotherapy treatment. The management of CIPN remains an important challenge and future studies are warranted before recommendations for the use of supplements can be made.
authors: The University of Queensland, School of Medicine, Centre for Integrative Clinical and Molecular Medicine, Level 5, TRI, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane 4102, Australia.
authors: Janet M
authors: JM
authors: Schloss
authors: Maree
authors: M
authors: Colosimo
authors: Caroline
authors: C
authors: Airey
authors: Paul P
authors: PP
authors: Masci
authors: Anthony W
authors: AW
authors: Linnane
authors: Luis
authors: L
authors: Vitetta
mesh_terms: D000108:Acetylcarnitine / Q000627:therapeutic use; D000111:Acetylcysteine / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005973:Glutamine / Q000627:therapeutic use; D005978:Glutathione / Q000627:therapeutic use; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D008063:Thioctic Acid / Q000627:therapeutic use; D014131:Trace Elements / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D015525:Fatty Acids, Omega-3; D014131:Trace Elements; D014815:Vitamins; D005973:Glutamine; D000108:Acetylcarnitine; D008063:Thioctic Acid; D005978:Glutathione; D000111:Acetylcysteine
keywords: CIPN; Chemotherapy induced peripheral neuropathy; Nutraceuticals; Vitamins